These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Methods for administration of anti-asthma inhalation drugs]. Fjellbirkeland L; Gulsvik A Tidsskr Nor Laegeforen; 1990 Jun; 110(16):2092-5. PubMed ID: 2368076 [TBL] [Abstract][Full Text] [Related]
24. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development. Crowder TM; Rosati JA; Schroeter JD; Hickey AJ; Martonen TB Pharm Res; 2002 Mar; 19(3):239-45. PubMed ID: 11934228 [TBL] [Abstract][Full Text] [Related]
25. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Bisgaard H; Klug B; Sumby BS; Burnell PK Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964 [TBL] [Abstract][Full Text] [Related]
26. Design, development and performance of a novel multidose dry-powder inhaler. Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653 [TBL] [Abstract][Full Text] [Related]
27. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler. Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187 [TBL] [Abstract][Full Text] [Related]
30. [Easyhaler--ideal dry powder inhaler]. Andrzej E; Małgorzata BE Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343 [TBL] [Abstract][Full Text] [Related]
31. The ideal inhaler for asthma therapy. Buck H Med Device Technol; 2001 Sep; 12(7):24-7. PubMed ID: 12938556 [TBL] [Abstract][Full Text] [Related]
32. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment. Westmeier R; Steckel H J Pharm Sci; 2008 Jun; 97(6):2299-310. PubMed ID: 17879293 [TBL] [Abstract][Full Text] [Related]
33. The clinical relevance of dry powder inhaler performance for drug delivery. Demoly P; Hagedoorn P; de Boer AH; Frijlink HW Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253 [TBL] [Abstract][Full Text] [Related]
34. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses. de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739 [TBL] [Abstract][Full Text] [Related]
35. Inhaler devices - from theory to practice. Sanchis J; Corrigan C; Levy ML; Viejo JL; Respir Med; 2013 Apr; 107(4):495-502. PubMed ID: 23290591 [TBL] [Abstract][Full Text] [Related]
36. Aerosol delivery systems in childhood asthma. Chauhan S; Gogtay JA Indian J Pediatr; 2001 Sep; 68 Suppl 4():S17-22. PubMed ID: 11980464 [TBL] [Abstract][Full Text] [Related]
38. Guidelines for devices and choices. Everard ML J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895 [TBL] [Abstract][Full Text] [Related]
39. Drug delivery to the lungs from dry powder inhalers. Newman SP Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S17-20. PubMed ID: 12974538 [TBL] [Abstract][Full Text] [Related]
40. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]